10 research outputs found

    Plant MetGenMAP: An Integrative Analysis System for Plant Systems Biology1[W][OA]

    No full text
    The information and resources generated from diverse “omics” technologies provide opportunities for producing novel biological knowledge. It is essential to integrate various kinds of biological information and large-scale omics data sets through systematic analysis in order to describe and understand complex biological phenomena. For this purpose, we have developed a Web-based system, Plant MetGenMAP, which can comprehensively integrate and analyze large-scale gene expression and metabolite profile data sets along with diverse biological information. Using this system, significantly altered biochemical pathways and biological processes under given conditions can be retrieved rapidly and efficiently, and transcriptional events and/or metabolic changes in a pathway can be easily visualized. In addition, the system provides a unique function that can identify candidate promoter motifs associated with the regulation of specific biochemical pathways. We demonstrate the functions and application of the system using data sets from Arabidopsis (Arabidopsis thaliana) and tomato (Solanum lycopersicum), respectively. The results obtained by Plant MetGenMAP can aid in a better understanding of the mechanisms that underlie interesting biological phenomena and provide novel insights into the biochemical changes associated with them at the gene and metabolite levels. Plant MetGenMAP is freely available at http://bioinfo.bti.cornell.edu/tool/MetGenMAP

    Small Molecule Injection into Single-Cell <i>C. elegans</i> Embryos via Carbon-Reinforced Nanopipettes

    Get PDF
    <div><p>The introduction of chemical inhibitors into living cells at specific times in development is a useful method for investigating the roles of specific proteins or cytoskeletal components in developmental processes. Some embryos, such as those of <i>Caenorhabditis elegans</i>, however, possess a tough eggshell that makes introducing drugs and other molecules into embryonic cells challenging. We have developed a procedure using carbon-reinforced nanopipettes (CRNPs) to deliver molecules into <i>C. elegans</i> embryos with high temporal control. The use of CRNPs allows for cellular manipulation to occur just subsequent to meiosis II with minimal damage to the embryo. We have used our technique to replicate classical experiments using latrunculin A to inhibit microfilaments and assess its effects on early polarity establishment. Our injections of latrunculin A confirm the necessity of microfilaments in establishing anterior-posterior polarity at this early stage, even when microtubules remain intact. Further, we find that latrunculin A treatment does not prevent association of PAR-2 or PAR-6 with the cell cortex. Our experiments demonstrate the application of carbon-reinforced nanopipettes to the study of one temporally-confined developmental event. The use of CRNPs to introduce molecules into the embryo should be applicable to investigations at later developmental stages as well as other cells with tough outer coverings.</p> </div

    Effect of Latrunculin A on PAR-6 localization.

    No full text
    <p>(<b>a</b>) Control with injection buffer containing 3.75% DMSO (<i>N</i> = 9). (<b>b</b>) Injection of 60 µM (<i>N</i> = 10) and (<b>c</b>) 90 µM (<i>N</i> = 5) LatA. In each panel, DIC is on the left and PAR-6::mCherry is on the right.</p

    Effect of Latrunculin A on PAR-2 localization in PAR-6-depleted embryos.

    No full text
    <p>(<b>a</b>) par <i>6</i> RNAi treatment for 24 hr (<i>N</i> = 5). (<b>b</b>) par <i>6</i> RNAi treatment for 24 hr combined with 90 µM LatA injection following meiosis II (<i>N</i> = 4). For each panel, columns from left to right: DIC, NMY-2::GFP/ GFP::H2B and PAR-2::mCherry.</p

    Effect of Latrunculin A concentration on PAR-2 localization.

    No full text
    <p>(<b>a</b>) Control with injection buffer containing 3.75% DMSO in 0.8x EB (<i>N</i> = 10). (<b>b</b>) Injection of 60 µM LatA (<i>N</i> = 8). Shown is an example embryo in which PAR-2 localized at both the cortex and the centrosomes. (<b>c</b>) Injection of 90 µM LatA (<i>N</i> = 13). Shown is an example embryo with PAR-2 localization at the centrosomes only. For each panel, columns from left to right: DIC; NMY2::GFP/GFP::H2B, and mCherry::PAR-2. In some images, only one centrosome is in focus. (<b>d</b>) Distribution of PAR-2 localization phenotypes after injection of 60 µM or 90 µM LatA. In this and all subsequent figures, rows of images are aligned by nuclear dynamics, as assessed by GFP::H2B.</p

    CRNP injection characterization and experimental configuration.

    No full text
    <p>(<b>a</b>) Characterization of injection volume. A differential interference contrast (DIC) image of a CRNP and fluorescence images before injection of dextran-TxRed into a droplet of glycerol and immediately after the injection. (<b>b</b>) Histogram of injection volume from multiple injections using one representative CRNP. (<b>c</b>) A cartoon and a (<b>d</b>) DIC image of the experimental configuration for embryo injection. A quartz holding pipette was used to immobilize the embryo during injection. Light suction applied through the holding pipette also allowed for the withdrawal of the CRNP. In all figures, unless otherwise stated, <i>t</i> = 0 is defined as the beginning of meiosis II, injection occurs at t <sup>≈</sup> 0: 15, anterior is to the left, and scale bars are 10 µm.</p

    Carbon-reinforced nanopipette (CRNP) fabrication.

    No full text
    <p>(<b>a</b>) CRNP fabrication procedure. Quartz capillaries were filled with Fe(NO<sub>3</sub>)<sub>3</sub> catalyst and left to dry, then pulled into pipettes of desired geometry. Carbon was grown within the pipette using chemical vapor deposition (CVD). (<b>b</b>) A SEM image of the tip of a CRNP, scale bar is 20 nm.</p

    Injection of YOYO-1 into multi-cell embryos.

    No full text
    <p>(a) Two-cell embryo in which the P1 blastomere has been injected with 1 µM YOYO-1. (<b>b</b>) Four-cell embryo in which the ABa blastomere has been injected with 1 µM YOYO-1.</p
    corecore